Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Malignant Melanoma

  Free Subscription


01.06.2020

6 Ann Surg Oncol
1 Br J Dermatol
1 Cancer
1 Int J Cancer
3 J Am Acad Dermatol
1 J Cell Physiol
1 J Clin Oncol
2 J Invest Dermatol
1 J Surg Oncol
1 Melanoma Res
1 Nat Med
1 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. NEUWIRTH MG, Bartlett EK
    Timing Is Everything: Could Surveillance Imaging Intensity Influence Survival in High-Risk Melanoma?
    Ann Surg Oncol. 2020 May 28. pii: 10.1245/s10434-020-08633.
    PubMed        

  2. IBRAHIM AM, Le May M, Bosse D, Marginean H, et al
    Correction to: Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence.
    Ann Surg Oncol. 2020 May 22. pii: 10.1245/s10434-020-08618.
    PubMed         Abstract available

  3. RAUWERDINK DJW, Molina G, Frederick DT, Sharova T, et al
    Adjuvant Therapy Failure Patterns in the Modern Era of Melanoma Management.
    Ann Surg Oncol. 2020 May 23. pii: 10.1245/s10434-020-08631.
    PubMed         Abstract available

  4. RAUWERDINK DJW, Boland GM
    ASO Author Reflections: Mixed Response in Metastatic Melanoma Patients Treated with Immunotherapy.
    Ann Surg Oncol. 2020 May 26. pii: 10.1245/s10434-020-08663.
    PubMed        

  5. MONCRIEFF M, Heaton M
    ASO Author Reflections: Improved Perioperative Seroma and Complication Rates Following the Application of a Two-Layer Negative Pressure Wound Therapy System After Inguinal Lymphadenectomy for Metastatic Cutaneous Melanoma.
    Ann Surg Oncol. 2020 May 27. pii: 10.1245/s10434-020-08525.
    PubMed        

  6. RAUWERDINK DJW, Boland GM
    ASO Author Reflections: Adjuvant Treatment of Melanoma in the Modern Era.
    Ann Surg Oncol. 2020 May 28. pii: 10.1245/s10434-020-08671.
    PubMed        


    Br J Dermatol

  7. JANDA M, Swetter SM, Horsham C, Soyer HP, et al
    Virtual melanoma checks during a pandemic.
    Br J Dermatol. 2020 May 29. doi: 10.1111/bjd.19255.
    PubMed         Abstract available


    Cancer

  8. PATRINELY JR JR, Baker LX, Davis EJ, Song H, et al
    Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma.
    Cancer. 2020 May 28. doi: 10.1002/cncr.32984.
    PubMed         Abstract available


    Int J Cancer

  9. HE Q, Li X, He L, Li Y, et al
    Pericyte dysfunction due to Shb gene deficiency increases B16F10 melanoma lung metastasis.
    Int J Cancer. 2020 May 22. doi: 10.1002/ijc.33110.
    PubMed         Abstract available


    J Am Acad Dermatol

  10. BRAGHIROLI NF, Grant-Kels JM, Oliviero M, Rabinovitz H, et al
    The role of reflectance confocal microscopy in differentiating melanoma in situ from dysplastic nevi with severe atypia: a cross-sectional study.
    J Am Acad Dermatol. 2020 May 19. pii: S0190-9622(20)30939.
    PubMed         Abstract available

  11. RACHIDI S, Deng Z, Sullivan DY, Lipson EJ, et al
    Shorter survival and later stage at diagnosis among unmarried patients with cutaneous melanoma: a US national and tertiary care center study.
    J Am Acad Dermatol. 2020 May 21. pii: S0190-9622(20)30958.
    PubMed         Abstract available

  12. GOLDSMITH SM
    Comment on "Re-Evaluating the ABCD Criteria Using a Consecutive Series of Melanomas".
    J Am Acad Dermatol. 2020 May 23. pii: S0190-9622(20)30970.
    PubMed        


    J Cell Physiol

  13. YU Y, Ladeiras D, Xiong Y, Boligan KF, et al
    Arginase-II promotes melanoma migration and adhesion through enhancing hydrogen peroxide production and STAT3 signaling.
    J Cell Physiol. 2020 May 29. doi: 10.1002/jcp.29814.
    PubMed         Abstract available


    J Clin Oncol

  14. FARIES MB
    Improved Tool for Predicting Sentinel Lymph Node Metastases in Melanoma.
    J Clin Oncol. 2020 May 28:JCO2001121. doi: 10.1200/JCO.20.01121.
    PubMed        


    J Invest Dermatol

  15. TRUCCO LD, Mundra PA, Garcia-Martinez P, Hogan K, et al
    Map3k1 Loss Cooperates With Braf(V600E) to Drive Melanomagenesis.
    J Invest Dermatol. 2020 May 22. pii: S0022-202X(20)31598.
    PubMed        

  16. SHIN SY, Choi JH, Jung E, Gil HN, et al
    The EGR1-STAT3 Transcription Factor Axis Regulates alpha-MSH-induced Tyrosinase Gene Transcription in Melanocytes.
    J Invest Dermatol. 2019 Jan 12. pii: S0022-202X(19)30010.
    PubMed        


    J Surg Oncol

  17. MEDINA BD, Choi BH, Rodogiannis KG, Moran U, et al
    Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
    J Surg Oncol. 2020 May 22. doi: 10.1002/jso.25987.
    PubMed         Abstract available


    Melanoma Res

  18. VIDARSDOTTIR L, Fernandes RV, Zachariadis V, Das I, et al
    Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib.
    Melanoma Res. 2020 May 27. doi: 10.1097/CMR.0000000000000675.
    PubMed         Abstract available


    Nat Med

  19. OSTENDORF BN, Bilanovic J, Adaku N, Tafreshian KN, et al
    Common germline variants of the human APOE gene modulate melanoma progression and survival.
    Nat Med. 2020 May 25. pii: 10.1038/s41591-020-0879.
    PubMed         Abstract available


    PLoS One

  20. SZTWIERTNIA I, Schenz J, Bomans K, Schaack D, et al
    Sevoflurane depletes macrophages from the melanoma microenvironment.
    PLoS One. 2020;15:e0233789.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  21. PYO A, Kim DY, Kim H, Lim D, et al
    Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
    Proc Natl Acad Sci U S A. 2020 May 21. pii: 1922313117.
    PubMed         Abstract available

  22. MULLOKANDOV G, Vijayakumar G, Leon P, Henry C, et al
    High-complexity extracellular barcoding using a viral hemagglutinin.
    Proc Natl Acad Sci U S A. 2020;117:2767-2769.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: